Tin tức & Cập nhật
Xem bài viết Hô hấp
Xem
Chỉ hiển thị Multimedia

Early antiviral treatment helps reduce risk of long COVID
23 May 2026
bởiJairia Dela Cruz
Individuals with acute COVID-19 who receive prompt antiviral treatment, such as ensitrelvir, nirmatrelvir, or molnupiravir, in the outpatient setting may be less likely to experience post–COVID-19 condition (PCC) compared with those who receive no treatment.
Early antiviral treatment helps reduce risk of long COVID
23 May 2026
Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?
12 May 2026
bởiAudrey Abella
Perioperative adebrelimab plus chemotherapy improves event-free survival (EFS) and major pathological response (MPR) in individuals with resectable stage II/III non-small cell lung cancer (NSCLC) in an interim analysis.
Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?
12 May 2026
Colchicine plus famotidine/loratadine helps reduce fatigue in long COVID
03 May 2026
bởiStephen Padilla
Treatment with colchicine and famotidine plus loratadine, in addition to specialist supportive care, can substantially ease severe fatigue among patients suffering from long COVID, as shown by the results of the STIMULATE ICP trial.






